Comparative Adverse Event Reporting of Asparaginase-Containing Induction Regimens in Pediatric Acute Lymphoblastic Leukemia Using the United States Food and Drug Administration Adverse Event Reporting System
Cureus · 01.05.2026
DOI: 10.7759/cureus.108119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 01.05.2026. Verfasst von Toru Ogura und 1 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Support Center, Mie University Hospital, Tsu, JPN. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Research Support Center, Mie University Hospital, Tsu, JPN.
- Department of Pharmaceutical Sciences for Health Crisis Management, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, JPN.
Zitieren
APA
Ogura, T., & Shiraishi, C. (2026). Comparative Adverse Event Reporting of Asparaginase-Containing Induction Regimens in Pediatric Acute Lymphoblastic Leukemia Using the United States Food and Drug Administration Adverse Event Reporting System. Cureus. https://doi.org/10.7759/cureus.108119
Vancouver
Ogura T, Shiraishi C. Comparative Adverse Event Reporting of Asparaginase-Containing Induction Regimens in Pediatric Acute Lymphoblastic Leukemia Using the United States Food and Drug Administration Adverse Event Reporting System. Cureus. 2026. doi:10.7759/cureus.108119
BibTeX
@article{Ogura2026,
author = {Ogura, Toru and Shiraishi, Chihiro},
title = {Comparative Adverse Event Reporting of Asparaginase-Containing Induction Regimens in Pediatric Acute Lymphoblastic Leukemia Using the United States Food and Drug Administration Adverse Event Reporting System},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.108119}
}
EUVIMED